Csl Ltd has released a press release.
CSL Vifor Market Briefing
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from CSL
- Finalisation of Vifor Pharma Acquisition
- Vifor update ASX Announcement for lodgement
- CSL successfully issues bonds in US debt markets
- Update on Acquisition of Vifor Pharma
- Statutory Accounts for Half Year Ended 31 December 2021
Later from CSL
- CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology
- Appointment of CSLs next CEO & Managing Director
- CSL Half Year Results Announcement & Investor Presentation
- CSL Statutory Accounts for the Half Year Ended 31 Dec 2022
- Market Update
Follow CSL into a list and get an email when it puts out news.
Follow CSL